Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 22, 2020 Off

First Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays

By BusinessWire

EF-33 will test the potential incremental survival benefit of Tumor Treating Fields delivered using high-intensity arrays in patients with recurrent…

July 22, 2020 Off

First Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays

By BusinessWire

EF-33 will test the potential incremental survival benefit of Tumor Treating Fields delivered using high-intensity arrays in patients with recurrent…

July 22, 2020 Off

LabVantage COVID-19 LIMS Solution Implemented for Onsite Workplace Health and Safety

By BusinessWire

—Leading Consumer Goods Company Offers Employee Health Testing at In-House Test Centers— SOMERSET, N.J.–(BUSINESS WIRE)–#COVID–LabVantage Solutions, Inc., the leading provider…

July 22, 2020 Off

LabVantage COVID-19 LIMS Solution Implemented for Onsite Workplace Health and Safety

By BusinessWire

—Leading Consumer Goods Company Offers Employee Health Testing at In-House Test Centers— SOMERSET, N.J.–(BUSINESS WIRE)–#COVID–LabVantage Solutions, Inc., the leading provider…

July 22, 2020 Off

Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

By BusinessWire

U.S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 500 million…

July 22, 2020 Off

Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

By BusinessWire

U.S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 500 million…

July 22, 2020 Off

Veeva Extends Remote Meeting Capabilities to Zoom and Microsoft Teams

By BusinessWire

Life sciences companies and doctors can leverage Veeva CRM Engage Meeting across the online meeting platforms they’re already using BARCELONA,…

July 22, 2020 Off

Veeva Extends Remote Meeting Capabilities to Zoom and Microsoft Teams

By BusinessWire

Life sciences companies and doctors can leverage Veeva CRM Engage Meeting across the online meeting platforms they’re already using BARCELONA,…

July 22, 2020 Off

Syneos Health Strengthens Commercial Services With Veeva Commercial Cloud

By BusinessWire

Leading biopharmaceutical services company brings together multichannel customer engagement, data, and content to speed commercial launches Addition of Veeva OpenData…

July 22, 2020 Off

Syneos Health Strengthens Commercial Services With Veeva Commercial Cloud

By BusinessWire

Leading biopharmaceutical services company brings together multichannel customer engagement, data, and content to speed commercial launches Addition of Veeva OpenData…

Posts pagination

Previous 1 … 4,720 4,721 4,722 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine